Table 3.
Complications with MIGS vs complications with tube vs trab vs nonpenetrating deep sclerectomy (NPDS)
Trab | Baerveldt | AGV | NPDS | MIGS | |
---|---|---|---|---|---|
Hyphema | 17.2%20 | 5%21 | 18.3%20 | 7.4%22 | 24.3% with Xen23 |
0.02% for iStent24,25 | |||||
19.04% for Hydrus26 | |||||
2.7% for Cypass27 | |||||
Hypotony | 31%28 | 13%28,29 | 2%29 | 9.9%22 | 13.8% with Cypass30 |
39.3%20 | 15.3% with Xen31 | ||||
13% with InnFocus17 | |||||
Shallow anterior chamber | 11.8%20 | 3%21 | 11.11%20 | 8.9%22 | 0–2.3%33 |
Choroidal detachment | 3.2–10.75%34 | 3%21 | 12%32 | 8.6%22 | 15.3% with Xen31 |
Progressive cataract | 35%35 | 8%29 | 8%29 | 6.6%22 | 12.2% with Cypass36 |
11.1% with iStent37 | |||||
Loss of light perception | 2%28 | 4%28 | 12%29 | ||
Bleb leak | 6.7%20 | ||||
Stent malpositioning | 12.2% with Xen23 | ||||
Stent obstruction | 4% with iStent38 | ||||
2.4–5.4% with Cypass27,30 | |||||
4.3% with InnFocus17 | |||||
Resurgery rates | 7–28%32,39 in 5 year period | 5.4–17%20,40 in 5 years | 17–40%,29,32 in 5 years | 3.7–5.4%41,42 after 1–3 years | 7.4% with iStent31 |
14.1% with Xen43 after 12 months of surgery | |||||
4.3% with InnFocus at 3 years17 |